I was wondering if anyone had knew about any risk involved
with intracerebroventricular (icv) injection/infusion of
peptides which require the addition of bovine serum albumin(bsa)
The bsa addition is per manufacturer recommendation to limit
peptide adhesion to the containers, & infusion minipump.
Would a dilution in the bsa (0.1-1%), promote immune
responses in the rat receiving the icv infusion (14day duration)?
Would I be better off not using bsa?
Thanks,
--
_
(_)
_______//
John T. Robicheau (________)
Pharmacodynamic Research Center \ Pitt /
University of Pittsburgh | Rx |
JTRst4 at vms.cis.Pitt.Edu /______\
Robich at DrugInfonet.Pharm-Epid.Pitt.Edu (________)
"A drug is something that when administered to a rat, produces a
scientific publication."